We also find shHK2DOX HK2 inhibition plus OXPHOS inhibition (in our case with DPI) reduces, but does not completely suppress, xenograft tumor progression for Huh7 (Fig. 6e) and Hep3B (Fig. 6a) HK1−HK2+ liver cancer xenografts. The gene discussed is HK2; the disease is neoplasm.